Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
49 studies found for:    metabolic syndrome | Open Studies | Interventional Studies | Adult | Phase 1, 2, 3 | Industry
Show Display Options
Rank Status Study
1 Not yet recruiting Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome
Condition: Metabolic Syndrome
Intervention: Drug: 3-V Bioscience-2640
2 Recruiting Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver Disease
Condition: Metabolic Syndrome X
Interventions: Dietary Supplement: Lactobacillus spp;   Dietary Supplement: Control
3 Recruiting NWT03 and Arterial Stiffness
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: NWT-03, an egg-white protein hydrolysate;   Other: Placebo
4 Recruiting Metformin in the Diastolic Dysfunction of Metabolic Syndrome
Conditions: Metabolic Syndrome X;   Diastolic Dysfunction;   Insulin Resistance
Interventions: Behavioral: Lifestyle Counseling;   Drug: Metformin
5 Recruiting Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
Condition: Non-alcoholic Fatty Liver Disease
Interventions: Drug: Runihol;   Other: Placebo
6 Not yet recruiting Safety and Efficacy Trial Using Allogeneic Human Mesenchymal Stem Cells: The SIRONA Trial
Conditions: Metabolic Disease;   Endothelial Dysfunction
Intervention: Biological: Peripheral Intravenous (IV) infusion of LMSCs
7 Recruiting Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents
Conditions: NAFLD;   TYPE 2 DIABETES;   METABOLIC SYNDROME
Interventions: Dietary Supplement: Resveratrol;   Dietary Supplement: Placebo
8 Recruiting Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
Conditions: Gestational Diabetes Mellitus;   Type 2 Diabetes Mellitus;   Metabolic Syndrome;   Impaired Glucose Tolerance;   Disorder of Glucose Regulation
Interventions: Drug: Metformin XR plus placebo;   Drug: Metformin XR plus liraglutide
9 Not yet recruiting Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Apalutamide;   Drug: IHT
10 Recruiting A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ASP4345;   Drug: Matching Placebo
11 Not yet recruiting Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Condition: Hurler Syndrome, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy, Krabbe, Cerebral Adrenoleukodystrophy
Intervention: Drug: Umbilical cord blood transplantation with HSC835
12 Recruiting DAPA, EQW, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Obesity
Interventions: Drug: Exenatide once weekly (EQW );   Drug: Dapagliflozin (DAPA);   Drug: EQW plus DAPA;   Drug: Dapagliflozin plus Glucophage (MET ER);   Drug: Phentermine /Topiramate (PHEN/ TRP) ER
13 Recruiting Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome (PCOS)
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo caplet of Metformin XR;   Drug: Placebo capsule of DLBS3233
14 Recruiting Ubiquinol as a Metabolic Resuscitator in Post-Cardiac Arrest
Condition: Post-Cardiac Arrest Syndrome
Interventions: Drug: Ubiquinol;   Dietary Supplement: Ensure
15 Not yet recruiting Pulsed Electromagnetic Field (PEMF) Therapy for Post-Concussive Syndrome
Conditions: Post Concussive Syndrome;   Concussion
Intervention: Device: PEMF
16 Recruiting PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
Conditions: Polycystic Ovary Syndrome (PCOS);   Insulin Resistance
Interventions: Drug: DLBS3233;   Drug: Metformin XR;   Drug: Placebo metformin;   Drug: Placebo DLBS3233
17 Recruiting An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome
Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Intervention: Drug: Triheptanoin
18 Recruiting Phase II Open Label Study Using Triheptanoin in Patients With Glucose Type 1 Transporter Deficiency GLUT1-DS
Condition: Glut1 Deficiency Syndrome
Intervention: Drug: GLUT1 DS
19 Not yet recruiting Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Condition: Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Interventions: Drug: UX007;   Drug: Placebo
20 Recruiting Treatment for Endogenous Cushing's Syndrome
Condition: Endogenous Cushing's Syndrome
Intervention: Drug: COR-003

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.